Late-onset immune-mediated adverse effects after poly-L-lactic acid injection in non-HIV patients: Clinical findings and long-term follow-up

Dermatology

Volumn 219, Issue 4, 2009, Pages 303-308

  Alijotas Reig, Jaume ^a,b   Garcia Gimenez, Victor ^a   Vilardell Tarres, Miquel ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b NONE   (Spain)

Author keywords

Dermal filler, complications; Lipo atrophy; Poly L lactic acid injection

Indexed keywords

ALLOPURINOL; BIO ALCAMID; DERMALIVE; HYDROXYCHLOROQUINE; POLYLACTIC ACID; PREDNISONE; TETRACYCLINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DRUG EFFECT; FACE EDEMA; FEMALE; FOLLOW UP; GRANULOMATOSIS; HUMAN; IMMUNE MEDIATED INJURY; LATENT PERIOD; LONG TERM CARE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUS; REMISSION; SARCOIDOSIS; SKIN EDEMA; SKIN INDURATION; SKIN NODULE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; BIOCOMPATIBLE MATERIALS; COHORT STUDIES; COSMETIC TECHNIQUES; EDEMA; FACE; FEMALE; FOLLOW-UP STUDIES; GRANULOMA, FOREIGN-BODY; HIV INFECTIONS; HUMANS; HYPERSENSITIVITY, DELAYED; INJECTIONS; LACTIC ACID; MIDDLE AGED; POLYMERS; PROSPECTIVE STUDIES; REJUVENATION; TREATMENT OUTCOME;

EID: 72449148141     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000243804     Document Type: Article

References (35)

1. De Boulle K: Management of complications after implantation of fillers. J Cosmet Dermatol 2004; 3: 2-15.
2. Ellis DA, Makdessian AS, Brown DJ: Survey of future injectables. Facial Plast Surg Clin North Am 2001; 9: 405-411.
3. Frank PJ: Cosmetic symposium: Restylane. The Dermatologic Society of Greater New York. Available at http://www.dermsociety. org/default.asp?id= 3&aui=sa&aid=35 (accessed February 2005).
4. Engelman DE, Bradley B, Goldberg DJ: Dermal fillers: Complications and informed consent. J Cosmet Laser Ther 2005; 7: 29-32.
5. Andre P, Lowe NJ, Parc A, Clerici TH, Zimmermann U: Adverse reactions to dermal fillers: A review of European experiences. J Cosmet Laser Ther 2005; 7: 171-176.
6. Duffy DM: Complications of fillers: Overview. Dermatol Surg 2005; 31: 1626-1633.
7. Sculptra M: Product information Sanofi- Aventis. 2006. http://products.sanofi-aventis. us/sculptra/sculptra.html (accessed August 2007).
8. Vleggaar D: Soft-tissue augmentation and the role of poly- L -lactic acid. Plast Reconstr Surg 2006; 118: 46S-54S.
9. Lam SM, Azizzadesh B, Garivier M: Injectable poly- L -lactic acid (Sculptra): Technical considerations in soft-tissue contouring. Plast Reconstr Surg 2006; 118: 55S-56S.
10. Vleggaar D: Poly- L -lactic acid: Consultation of the injection techniques. J Eur Acad Dermatol Venereol 2006; 118(suppl):55S-63S.
11. Engelhard P, Humble G, Mest D: Safety of Sculptra: A review of clinical trial data. J Cosmet Laser Ther 2005; 7: 201-205.
12. Reszko AE, Sadick NS, Magro CM, Farber J: Late-onset subcutaneous nodules after poly- L -lactic acid injection. Dermatol Surg 2009; 35: 380-384.
13. Beer K: Clinicopathologic correlation of delayed-onset periorbital poly- L -lactic acid nodules. Dermatol Surg 2009; 35: 399-402.
14. Dijkeman S, van der Lei B, Kibbelaar RE: New-Fill injections may induce late-onset foreign body granulomatous reaction. Plast Reconstr Surg 2005; 115: 76e-78e.
15. Hamilton DG, Gauthier N, Robertson BF: Late-onset, recurrent facial nodules associated with injection of poly- L -lactic acid. Dermatol Surg 2008; 34: 123-126.
16. Mest DR, Humble GM: Retreatment with injectable poly- L -lactic acid for HIV-associated facial lipoatrophy: 24-month extension of the Blue Pacific Study. Dermatol Surg 2009; 35: 350-359.
17. Saylan Z: Facial fillers and their complications. Aesthet Surg J 2003; 23: 221-224.
18. Valantin MA, Aubron-Olivier C, Ghosn J, Laglenne E, Pauchard M, Schoen H: Polylactic acid implants to correct facial lipoatrophy in HIV-infected patients: Results of the openlabel study VEGA. AIDS 2003; 17: 2471-2477.
19. Alijotas-Reig J, Garcia-Gimenez V, Miró- Mur F, Vilardell-Tarrés M: Delayed immune- mediated adverse effects of polyalkylimide dermal fillers: Clinical findings and long-term follow-up. Arch Dermatol 2008; 144: 637-642.
20. Alijotas-Reig J, Garcia-Gimenez V, Miró- Mur F, Vilardell-Tarrés M: Delayed immune- mediated adverse effects related to polyacrylamide dermal fillers: Clinical findings, management and follow-up. Dermatol Surg 2009; 35(suppl 1):360-366.
21. Christensen L, Breiting V, Janssen M, Vuust J, Hogdall E: Adverse reactions to injectable soft tissue permanent fillers. Aesthet Plast Surg 2005; 29: 34-48.
22. Alijotas-Reig J, Garcia-Gimenez V: Delayed immune-mediated adverse effects related to hyaluronic acid and acrylic hydrogel dermal fillers: Clinical findings, long-term follow-up and review of the literature. J Eur Acad Dermatol Venereol 2008; 22: 150-161.
23. Brady JM, Cutright DE, Miller RA, Barristone GC: Resorption rate, route of elimination and ultrastructure of the implant site of poly- L -lactic acid in the abdominal wall of the rat. J Biomed Mater Res 1973; 7: 155-156.
24. Cutright DE, Hunsuck EE: Tissue reaction to the biodegradable polylactic acid suture. Oral Surg Oral Med Oral Pathol 1971; 31: 134-139.
25. Burgess CM, Quiroga RM: Assessment of the safety and efficacy of poly- L -lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol 2005; 52: 233-239.
26. Lowe NJ, Maxwell CA, Lowe P, Shah A, Patnaik R: Injectable poly- L -lactic acid: 3 years of aesthetic experience. Dermatol Surg 2009; 35: 344-349.
27. Mest DR, Humble GM: Safety and efficacy of poly- L -lactic acid injections in persons with HIV-associated facial lipoatrophy: The US experience. Dermatol Surg 2006; 32: 1336-1345.
28. Antonovic D, Callen J: Development of sarcoidosis in cosmetic tattoos. Arch Dermatol 2005; 141: 869-872.
29. Dal Sacco D, Cozzani E, Parodi A, Rebora A: Scar sarcoidosis after hyaluronic acid injection. Int J Dermatol 2005; 44: 411-412.
30. Lombardi T, Samson J, Plantier F, Husson C, Kuffer R: Orofacial granulomas after injection of cosmetic fillers: Histopathologic and clinical study of 11 cases. J Oral Pathol Med 2004; 33: 115-120.
31. Rynes RI: Antimalarial drugs; in Kelley WN, Harris ED, Ruddyn S, Sledge CB (eds): Textbook of Rheumatology, ed 4. Philapelphia, Saunders, 1993, pp 731-742.
32. Lowe NJ, Maxwell CA, Patnaik R: Adverse reactions to dermal fillers: Review. Dermatol Surg 2005; 31: 1616-1619.
33. Reisemberger EM, Landthaler M, Wiest I, Schröeder J, Stolz W: Foreign body granulomas caused by polymethylmethacrylate microspheres: Successful treatment with allopurinol. Arch Dermatol 2003; 139: 17-20. (Pubitemid 36091569)
34. Brechtel B, Haass N, Henz BM, Kolde G: Allopurinol: A therapeutic alternative for disseminated cutaneous sarcoidosis. Br J Dermatol 1996; 135: 307-309.
35. Senet P, Bachelez H, Ollivaud L, Vignon- Pennamen D, Dubertret L: Minocycline for the treatment of cutaneous silicone granulomas. Br J Dermatol 1999; 140: 985-987.